A population-based cross-sectional study of colorectal cancer screening practices of first-degree relatives of colorectal cancer patients

作者:Courtney Ryan J*; Paul Christine L; Carey Mariko L; Sanson Fisher Robert W; Macrae Finlay A; D' Este Catherine; Hill David; Barker Daniel; Simmons Jody
来源:BMC Cancer, 2013, 13: 13.
DOI:10.1186/1471-2407-13-13

摘要

Background: The aim of this study was to determine the proportions and predictors of first-degree relatives (FDRs) of colorectal cancer (CRC) patients (i) ever receiving any CRC testing and (ii) receiving CRC screening in accordance with CRC screening guidelines. %26lt;br%26gt;Methods: Colorectal cancer patients and their FDRs were recruited through the population-based Victorian Cancer Registry, Victoria, Australia. Seven hundred and seven FDRs completed telephone interviews. Of these, 405 FDRs were deemed asymptomatic and eligible for analysis. %26lt;br%26gt;Results: Sixty-nine percent of FDRs had ever received any CRC testing. First-degree relatives of older age, those with private health insurance, siblings and FDRs who had ever been asked about family history of CRC by a doctor were significantly more likely than their counterparts to have ever received CRC testing. Twenty-five percent of FDRs %26quot;at or slightly above average risk%26quot; were adherent to CRC screening guidelines. For this group, adherence to guideline-recommended screening was significantly more likely to occur for male FDRs and those with a higher level of education. For persons at %26quot;moderately increased risk%26quot; and %26quot;potentially high risk%26quot;, 47% and 49% respectively adhered to CRC screening guidelines. For this group, guideline-recommended screening was significantly more likely to occur for FDRs who were living in metropolitan areas, siblings, those married or partnered and those ever asked about family history of CRC. %26lt;br%26gt;Conclusions: A significant level of non-compliance with screening guidelines was evident among FDRs. Improved CRC screening in accordance with guidelines and effective systematic interventions to increase screening rates among population groups experiencing inequality are needed. %26lt;br%26gt;Trial Registration: Australian and New Zealand Clinical Trial Registry: ACTRN12609000628246

  • 出版日期2013-1-10